Division of Energy Employees Occupational Illness Compensation (DEEOIC)
BULLETIN 19-03 Evaluation of Part E claims due to updates to Exhibit 15-4 of the Federal Energy Employees Occupational Illness Compensation Program Act (EEOICPA) Procedure Manual (Version 2.3)
As part of our ongoing efforts to ensure that the Division of Energy Employees Occupational Illness Compensation (DEEOIC) adjudicates claims in accordance with current medical and scientific standards, DEEOIC published several changes to the Procedure Manual (Version 2.3) given specific input from the Advisory Board on Toxic Substances and Worker Health. The edits to the Procedure Manual included changes to presumptive standards applied for evaluating claims for bladder cancer, hearing loss, lung cancer, mesothelioma, ovarian cancer, and pleural plaques. These changes were incorporated into the current version of the Procedure Manual under Exhibit 15-4, and are described below:
- Reduced the days of aggregate exposure to asbestos from 250 days to 30 days and the latency period from 30 years to 15 years for mesothelioma.
- Reduced the latency period for exposure to asbestos from 20 years to 15 years for ovarian cancer.
- Reduced the latency period for exposure to asbestos from 20 years to 10 years for pleural plaques.
- Added Benzidine as an agent related to bladder cancer.
- Added Carbon Disulfide and n-Hexane as agents related to hearing loss.
- Added a presumption about lung cancer related to asbestos exposure.*
*Excerpt from Bulletin 19-03; click below to view entire bulletin.